Lynx Signs, Renews Contracts for MPSS Gene Expression Service | GenomeWeb

This story has been updated from a previous version.


NEW YORK, May 13 (GenomeWeb News) - Lynx Therapeutics has signed three new contracts and renewed two others for its Massively Parallel Signature Sequencing gene expression analysis service, the company said today.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.